ask="5.00"
ask_size="100"
average_daily_volume="154939"
bid="3.80"
bid_size="800"
book_value="2.35"
change="+0.00"
change_from_200_day_moving_average="-0.26"
change_from_50_day_moving_average="0.41"
change_from_52_week_high="-6.84"
change_From_52_week_low="0.99"
change_in_percent="+0.00%"
close="4.75"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.01"
ebitda="-69.51M"
eps_estimate_current_year="-1.09"
eps_estimate_next_quarter="-0.27"
eps_estimate_next_year="-1.17"
ex_dividend_date="N/A"
float_shares="24548000"
high="4.82"
high_52_weeks="11.59"
last_trade_date="3/17/2017"
last_trade_price="4.75"
last_trade_size="1095"
last_trade_time="4:00pm"
low="4.58"
low_52_weeks="3.76"
market_capitalization="336.28M"
moving_average_200_day="5.01"
moving_average_50_day="4.34"
name="Adaptimmune Therapeutics plc - "
notes="N/A"
one_year_target_price="14.33"
open="4.79"
pe_ratio="N/A"
peg_ratio="0.11"
percent_change_from_200_day_moving_average="-5.12%"
percent_change_from_50_day_moving_average="+9.52%"
percent_change_from_52_week_high="-59.01%"
percent_change_from_52_week_low="+26.33%"
previous_close="4.75"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.02"
price_per_sales="23.68"
revenue="14.20M"
shares_outstanding="70795000"
short_ratio="4.44"
stock_exchange="NMS"
symbol="ADAP"
volume="114412"
weeks_range_52="3.76 - 11.59"
